On average, cold emails only have a 0.9% response rate. It’s hard to stand out in a crowded inbox, and it’s only going to get harder. New email sender guidelines have been out for a couple years now.
An objective response rate of 48.2% was observed with ifinatamab deruxtecan in these previously treated patients Discussions with global regulatory authorities underway SCLC is aggressive and ...
Cold emailing is a trusted marketing and selling tool. However, older techniques need to evolve over time to produce better results to align with recent trends. If you continue relying on outdated ...
DENVER -- Biological agents targeting interleukin-4 receptor alpha (IL-4Rα) in atopic dermatitis (AD) achieved rapid and substantial improvement in up to three-fourths of patients, according to ...
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
Cohort 3 analysis from the BREAKWATER study shows objective response rate of 64% with BRAFTOVI plus cetuximab and FOLFIRI compared to 39% with standard-of-care treatment FOLFIRI with or without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results